NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq: SDIX) – a leading provider of biotechnology-based detection solutions for a broad range of life science, food, water, agricultural and environmental applications – announced that it will be expanding its relationship with the University of Oregon, Eugene and the Louisiana State University Health Science Center, New Orleans (LSUHSC) by beginning to supply antibodies for the study of Usher Syndrome. The antibodies will be used in the researchers’ unique zebrafish and mouse model systems of the disease. The Usher Syndrome research community has made great strides in understanding the genetics of the disease, but progress has been hindered due to a lack of effective tools to understand the dynamics of the proteins associated with the disease. Dr. Monte Westerfield of U. of Oregon commented, “These tools will enable us to visualize the complex interaction of proteins in our disease models. Our initial tests of SDI’s antibodies have already produced surprising results that will help in unraveling the pathology behind this disease.” SDI will produce the antibodies through its proprietary Genomic Antibody Technology™ platform.
